Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt N/A
CUTR's Cash to Debt is ranked higher than
97% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. CUTR: N/A )
Ranked among companies with meaningful Cash to Debt only.
CUTR' s Cash to Debt Range Over the Past 10 Years
Min: N/A  Med: 10000.00 Max: No Debt
Current: N/A

Warning: Division by zero in /home/gurufocu/public_html/include/common_stock_functions_2.php on line 6548
N/A
No Debt
Equity to Asset 0.65
CUTR's Equity to Asset is ranked higher than
51% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. CUTR: 0.65 )
Ranked among companies with meaningful Equity to Asset only.
CUTR' s Equity to Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.82 Max: 0.87
Current: 0.65
0.31
0.87
Interest Coverage No Debt
CUTR's Interest Coverage is ranked higher than
94% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 481.81 vs. CUTR: No Debt )
Ranked among companies with meaningful Interest Coverage only.
CUTR' s Interest Coverage Range Over the Past 10 Years
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
F-Score: 5
Z-Score: 4.08
M-Score: -2.80
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -4.77
CUTR's Operating margin (%) is ranked lower than
62% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. CUTR: -4.77 )
Ranked among companies with meaningful Operating margin (%) only.
CUTR' s Operating margin (%) Range Over the Past 10 Years
Min: -20.83  Med: -7.94 Max: 22.05
Current: -4.77
-20.83
22.05
Net-margin (%) -4.69
CUTR's Net-margin (%) is ranked lower than
61% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. CUTR: -4.69 )
Ranked among companies with meaningful Net-margin (%) only.
CUTR' s Net-margin (%) Range Over the Past 10 Years
Min: -32.93  Med: -7.42 Max: 18.25
Current: -4.69
-32.93
18.25
ROE (%) -7.47
CUTR's ROE (%) is ranked lower than
63% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. CUTR: -7.47 )
Ranked among companies with meaningful ROE (%) only.
CUTR' s ROE (%) Range Over the Past 10 Years
Min: -16.6  Med: -6.30 Max: 16.66
Current: -7.47
-16.6
16.66
ROA (%) -5.44
CUTR's ROA (%) is ranked lower than
60% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. CUTR: -5.44 )
Ranked among companies with meaningful ROA (%) only.
CUTR' s ROA (%) Range Over the Past 10 Years
Min: -13.66  Med: -5.07 Max: 14.34
Current: -5.44
-13.66
14.34
ROC (Joel Greenblatt) (%) -177.88
CUTR's ROC (Joel Greenblatt) (%) is ranked lower than
77% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. CUTR: -177.88 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CUTR' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -1247.08  Med: -200.75 Max: 312.88
Current: -177.88
-1247.08
312.88
Revenue Growth (3Y)(%) 7.80
CUTR's Revenue Growth (3Y)(%) is ranked higher than
67% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. CUTR: 7.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CUTR' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -18.1  Med: 10.15 Max: 54.9
Current: 7.8
-18.1
54.9
EBITDA Growth (3Y)(%) -2.90
CUTR's EBITDA Growth (3Y)(%) is ranked lower than
57% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. CUTR: -2.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CUTR' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -29.5  Med: 26.00 Max: 89.8
Current: -2.9
-29.5
89.8
EPS Growth (3Y)(%) 0.70
CUTR's EPS Growth (3Y)(%) is ranked lower than
52% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. CUTR: 0.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CUTR' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -29.6  Med: 40.00 Max: 144.8
Current: 0.7
-29.6
144.8
» CUTR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

CUTR Guru Trades in Q1 2015

Jim Simons 814,100 sh (+4.48%)
Charles Brandes Sold Out
Mario Gabelli 635,000 sh (-2.31%)
» More
Q2 2015

CUTR Guru Trades in Q2 2015

Jim Simons 929,570 sh (+14.18%)
Mario Gabelli 635,000 sh (unchged)
» More
Q3 2015

CUTR Guru Trades in Q3 2015

Jim Simons 918,400 sh (-1.20%)
Mario Gabelli 605,000 sh (-4.72%)
» More
Q4 2015

CUTR Guru Trades in Q4 2015

Jim Simons 993,831 sh (+8.21%)
Mario Gabelli 605,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with CUTR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 23.20
CUTR's Forward P/E is ranked lower than
67% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 18.66 vs. CUTR: 23.20 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 2.90
CUTR's P/B is ranked lower than
54% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 2.63 vs. CUTR: 2.90 )
Ranked among companies with meaningful P/B only.
CUTR' s P/B Range Over the Past 10 Years
Min: 0.68  Med: 1.57 Max: 5.4
Current: 2.9
0.68
5.4
P/S 1.75
CUTR's P/S is ranked higher than
62% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 2.24 vs. CUTR: 1.75 )
Ranked among companies with meaningful P/S only.
CUTR' s P/S Range Over the Past 10 Years
Min: 0.93  Med: 2.06 Max: 7.7
Current: 1.75
0.93
7.7
Current Ratio 3.09
CUTR's Current Ratio is ranked higher than
56% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. CUTR: 3.09 )
Ranked among companies with meaningful Current Ratio only.
CUTR' s Current Ratio Range Over the Past 10 Years
Min: 2.5  Med: 6.77 Max: 9.09
Current: 3.09
2.5
9.09
Quick Ratio 2.52
CUTR's Quick Ratio is ranked higher than
59% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. CUTR: 2.52 )
Ranked among companies with meaningful Quick Ratio only.
CUTR' s Quick Ratio Range Over the Past 10 Years
Min: 2.21  Med: 6.31 Max: 8.66
Current: 2.52
2.21
8.66
Days Inventory 91.60
CUTR's Days Inventory is ranked higher than
61% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. CUTR: 91.60 )
Ranked among companies with meaningful Days Inventory only.
CUTR' s Days Inventory Range Over the Past 10 Years
Min: 63.96  Med: 103.36 Max: 137.01
Current: 91.6
63.96
137.01
Days Sales Outstanding 34.72
CUTR's Days Sales Outstanding is ranked higher than
91% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. CUTR: 34.72 )
Ranked among companies with meaningful Days Sales Outstanding only.
CUTR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.62  Med: 33.12 Max: 52.02
Current: 34.72
22.62
52.02
Days Payable 23.98
CUTR's Days Payable is ranked lower than
85% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 59.85 vs. CUTR: 23.98 )
Ranked among companies with meaningful Days Payable only.
CUTR' s Days Payable Range Over the Past 10 Years
Min: 18.13  Med: 23.02 Max: 36.15
Current: 23.98
18.13
36.15

Valuation & Return

vs
industry
vs
history
Price/Net Cash 6.77
CUTR's Price/Net Cash is ranked higher than
73% of the 143 Companies
in the Global Medical Devices industry.

( Industry Median: 12.35 vs. CUTR: 6.77 )
Ranked among companies with meaningful Price/Net Cash only.
CUTR' s Price/Net Cash Range Over the Past 10 Years
Min: 1.2  Med: 2.48 Max: 8.12
Current: 6.77
1.2
8.12
Price/Net Current Asset Value 3.13
CUTR's Price/Net Current Asset Value is ranked higher than
80% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 9.50 vs. CUTR: 3.13 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
CUTR' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.91  Med: 1.91 Max: 23.73
Current: 3.13
0.91
23.73
Price/Tangible Book 2.99
CUTR's Price/Tangible Book is ranked higher than
66% of the 362 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. CUTR: 2.99 )
Ranked among companies with meaningful Price/Tangible Book only.
CUTR' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.77  Med: 1.85 Max: 20.59
Current: 2.99
0.77
20.59
Price/Projected FCF 1090.00
CUTR's Price/Projected FCF is ranked lower than
100% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 1.94 vs. CUTR: 1090.00 )
Ranked among companies with meaningful Price/Projected FCF only.
CUTR' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.45  Med: 1.02 Max: 1308
Current: 1090
0.45
1308
Price/Median PS Value 0.84
CUTR's Price/Median PS Value is ranked higher than
67% of the 374 Companies
in the Global Medical Devices industry.

( Industry Median: 0.99 vs. CUTR: 0.84 )
Ranked among companies with meaningful Price/Median PS Value only.
CUTR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.53  Med: 1.04 Max: 2.56
Current: 0.84
0.53
2.56
Earnings Yield (Greenblatt) (%) -7.82
CUTR's Earnings Yield (Greenblatt) (%) is ranked lower than
73% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. CUTR: -7.82 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CUTR' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -7.82  Med: 6.40 Max: 795.7
Current: -7.82
-7.82
795.7

More Statistics

Revenue(Mil) $90
EPS $ -0.56
Beta0.56
Short Percentage of Float3.44%
52-Week Range $10.16 - 16.37
Shares Outstanding(Mil)12.93

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 104 112 121
EPS($) 0.30 0.45 0.60
EPS without NRI($) 0.30 0.45 0.60

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:TJ9.Germany,
Cutera Inc was established in the San Francisco Bay Area in 1998. It is a medical device company, specializing in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. It offers easy-to-use products based on four main platforms/systems Xeo, GenesisPlus, ExcelV, and truSculpt, each of which enables physicians and other qualified practitioners to perform safe and effective aesthetic procedures for their customers. The Xeo is a multi-application platform on which a customer can purchase hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, improving texture, reducing pore size, and treating fine lines and laxity. GenesisPlus platform, is a dedicated laser system for performing aesthetic skin procedures and for the temporary increase of clear nail in patients with onychomycosis, or toenail fungus. ExcelV is a high-performance, vascular platform designed specifically for the core-market of Dermatologists and Plastic Surgeons. This platform provides a combination of the 532 nm green laser with Cutera's award-winning 1064 nm Nd:YAG technology, to provide a single, compact and efficient system that treats the entire range of cosmetic vascular conditions, without the need for costly consumables. truSculpt is a high-powered radio frequency platform designed for the non-invasive body contouring market. This system is designed to treat all body areas and with its electrode design is able to achieve comfortable, uniform heating of the subcutaneous fat. In the U.S. its markets and sells its products mainly through a direct sales organization. International sales are generally made through a distributor network in over 60 countries. As of December 31, 2013, the Company had 30 issued U.S. patents and 11 pending U.S. patent applications. Its registered trademarks include Cutera, Acutip 500, CoolGlide, CoolGlide Excel, Limelight, myQ, Pearl, ProWave 770, ProWave LX, Solera, Titan, Xeo and truSculpt. The Company's products competes against laser and other energy-based products offered by public companies, such as Cynosure, Elen (in Italy), Lumenis, Syneron and Zeltiq, as well as private companies, including, Alma, Sciton, and several others. Its products are medical devices subject to extensive and rigorous regulation by the U.S. Food and Drug Administration, as well as other regulatory bodies.
» More Articles for NAS:CUTR

Headlines

Articles On GuruFocus.com
Chuck Royce's Top Five Second Quarter Portfolio Increases Aug 07 2013 
Gurus Buy Micro Caps – Bamboo Toilet Paper Jul 24 2013 
Guru Weekly Real Time Update Jul 05 2013 
Mario Gabelli and Jean-Marie Eveillard's Real Time Increases Jul 02 2013 
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 

More From Other Websites
Kendall Jenner sues skin care company for $10 mln over ad Feb 11 2016
Cutera (CUTR) Shows Strength: Stock Adds 5.2% in Session Feb 10 2016
Edited Transcript of CUTR earnings conference call or presentation 8-Feb-16 10:00pm GMT Feb 08 2016
Cutera Inc Earnings Call scheduled for 5:00 pm ET today Feb 08 2016
Cutera posts 4Q profit Feb 08 2016
Cutera posts 4Q profit Feb 08 2016
CUTERA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 08 2016
Cutera Reports Fourth Quarter 2015 Results Feb 08 2016
Q4 2015 Cutera Inc Earnings Release - After Market Close Feb 08 2016
Cutera, Inc. to Announce Results for the Fourth Quarter Ended December 31, 2015 Jan 26 2016
Cutera, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 24 2015
How it All Plays Out - Free Research Reports on Hill International, Marinus Pharmaceuticals, Ampio... Dec 18 2015
CUTERA INC Financials Dec 08 2015
Equities on the Move - Research on Guidance Software, Impac Mortgage, Cutera and Ducommun Nov 30 2015
Hedge Funds Are Selling Cutera, Inc. (CUTR) Nov 28 2015
Here is What Hedge Funds Think About New America High Income Fund Inc. (HYB) Nov 25 2015
Why Cutera (CUTR) Stock Might be a Great Pick Nov 20 2015
New Strong Buy Stocks for November 12th Nov 12 2015
Cutera Reports Third Quarter 2015 Results Nov 09 2015
Edited Transcript of CUTR earnings conference call or presentation 2-Nov-15 10:00pm GMT Nov 02 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK